Islay Capital Management’s AbbVie ABBV Stock Holding History

Islay Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-350	Closed	-$69.1K	–	205
2024 Q3	$69.1K	Hold	350	–	–	0.05%	115
2024 Q2	$60K	Hold	350	–	–	0.04%	121
2024 Q1	$63.7K	Hold	350	–	–	0.05%	117
2023 Q4	$54.2K	Hold	350	–	–	0.04%	128
2023 Q3	$52.2K	Hold	350	–	–	0.04%	127
2023 Q2	$47.2K	Hold	350	–	–	0.04%	131
2023 Q1	$55.8K	Hold	350	–	–	0.05%	127
2022 Q4	$56.6K	Hold	350	–	–	0.06%	124
2022 Q3	$47K	Hold	350	–	–	0.06%	141
2022 Q2	$54K	Hold	350	–	–	0.06%	179
2022 Q1	$57K	Hold	350	–	–	0.05%	188
2021 Q4	$47K	Hold	350	–	–	0.04%	187
2021 Q3	$38K	Hold	350	–	–	0.03%	208
2021 Q2	$39K	Hold	350	–	–	0.03%	205
2021 Q1	$38K	Hold	350	–	–	0.03%	187
2020 Q4	$38K	Hold	350	–	–	0.03%	186
2020 Q3	$31K	Sell	350 -4,827	-93%	-$454K	0.03%	193
2020 Q2	$508K	Buy	5,177 +55	+1%	+$4.84K	0.59%	40
2020 Q1	$390K	Sell	5,122 -868	-14%	-$73.9K	0.51%	39
2019 Q4	$530K	Buy	+5,990	New	+$497K	0.51%	40

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Islay Capital Management's ABBV Position: Q4 2024 in Review

Islay Capital Management sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 350 shares — an estimated $69.1K sold.

Islay Capital Management first reported a position in ABBV in Q4 2019 and held it in 20 quarters. The position peaked at $530K in Q4 2019. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

Islay Capital Management reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
Islay Capital Management sold 350 AbbVie shares in Q4 2024, an estimated $69.1K.
Islay Capital Management first reported a position in AbbVie in Q4 2019 and held it in 20 quarters.
Islay Capital Management's AbbVie position peaked at $530K in Q4 2019.
3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Islay Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.